[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339807-105":59,"doc-detail-339807-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","the-immunomodulatory-role-of-paracrine-signalling-factor-vsig4-in-peritoneal-metastases","The immunomodulatory role of paracrine signalling factor VSIG4 in peritoneal metastases","","Peritoneal metastasis (PM) is a common and deadly progression of colorectal cancer, yet effective long-lasting immunotherapy strategies remain to be established. This study identifies immunomodulatory factors linked to colorectal PM by analyzing a publicly available colorectal single-cell dataset to detect macrophage activation markers, including VSIG4. VSIG4 expression was tested on colorectal tumor microarrays and measured in cell-free ascites by ELISA. Low stromal VSIG4 correlated with poor prognosis, while ascites showed variable VSIG4 levels, supporting a potential therapeutic role in CPM.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-immunomodulatory-role-of-paracrine-signalling-factor-vsig4-in-peritoneal-metastases/339807/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-immunomodulatory-role-of-paracrine-signalling-factor-vsig4-in-peritoneal-metastases/339807.png","ImageObject",300,407,{"name":92,"@type":93},"Oliver","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main goal of this study on VSIG4 in colorectal PM?","Question",{"text":113,"@type":114},"To identify immunomodulatory factors associated with colorectal peritoneal metastases, focusing on the macrophage-related marker VSIG4 and its potential role in anti-inflammatory tumor microenvironments.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How was VSIG4 expression evaluated in the study?",{"text":118,"@type":114},"VSIG4 expression was assessed using immunohistochemical analysis on colorectal tumor microarrays, and its presence in cell-free ascites from PM patients was quantified using ELISA.",{"name":120,"@type":111,"acceptedAnswer":121},"What relationship was observed between VSIG4 expression and patient prognosis?",{"text":122,"@type":114},"CRCTMA staining indicated that low VSIG4 expression in stromal tissues of primary colorectal cancer was associated with poorer prognosis.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},339807,1790463347,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},8796095461610,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nThe immunomodulatory role of paracrine signalling factor VSIG4 in peritoneal metastases  \nYikYan Chong1,2,3,9, Sasinthiran Thiagarajan1,2,3,9, Qiu Xuan Tan1,2,3, Hui Jun Lim1,2,3, Joey Wee‑Shan Tan1,2,3, Josephine Hendrikson1,2,3, Gillian Ng1,2,3, Ying Liu1,2,3,  \nClara Yieh Lin Chong1,2,3, Wanyu Guo1,2,3, NyeThane Ngo4, Wei‑Qiang Leow4, Tracy Loh4, Xin Xiu Sam4, Tony Kiat Hon Lim4, Mingzhe Cai2,3, Chin Jin Seo2,3, Jolene Si Min Wong2,3, Khee Chee Soo2,3, Claramae Shulyn Chia2,3,5,6, Nicholas Brian Shannon7 &  \nChin‑Ann Johnny Ong1,2,3,5,6,8*  \nPeritoneal metastasis (PM), the regional progression of intra‑abdominal malignancies, is a common sequelae of colorectal cancer (CRC). Immunotherapy is slated to be effective in generating long‑ lasting anti‑tumour response as it utilizes the specificity and memory of the immune system. In the tumour microenvironment, tumour associated macrophages (TAMs) are posited to create an anti‑ inflammatory pro‑tumorigenic environment. In this paper, we aimed to identify immunomodulatory factors associated with colorectal PM (CPM). A publicly available colorectal single cell database (GSE183916) was analysed to identify possible immunological markers that are associated with the activation of macrophages in cancers. Immunohistochemical analysis for V‑set and immunoglobin containing domain 4 (VSIG4) expression was performed on tumour microarrays (TMAs) of tumours of colorectal origin (n = 211) . Expression of VSIG4 in cell‑free ascites obtained from CPM patients  \n(n = 39) was determined using enzyme‑linked immunosorbent assay (ELISA). CD163‑positive TAMs cluster expression was extracted from a publicly available single cell database and evaluated for the top 100 genes. From these macrophage‑expressed genes, VSIG4, a membrane protein produced by the M2 macrophages, mediates the up‑regulation of anti‑inflammatory and down‑regulation of pro‑inflammatory macrophages, contributing to an overall anti‑inflammatory state. CRCTMA IHC staining showed that low expression of VSIG4 in stromal tissues of primary CRC are associated with poor prognosis (p = 0.0226). CPM ascites also contained varying concentrations of VSIG4, which points to a possible role of VSIG4 in the ascites. The contribution of VSIG4 to CPM development can be further evaluated for its potential as an immunotherapeutic agent.  \nAt the incidence rate of one to two million cases worldwide, colorectal cancer (CRC) is one of the top common cancers, claiming a high mortality rate, second only to lung, liver, and gastric cancers1. Often, colorectal cancers present with peritoneal metastases (PM) as a manifestation of the locoregional spread of the tumour to the peritoneum2, with significantly poorer prognosis compared to metastasis to other regions of the body3. Current management of PM includes cytoreductive surgery (CRS) coupled with hyperthermic intraperitoneal chemotherapy (HIPEC) and systemic chemotherapy. CRS-HIPEC is the only curative treatment for PM in view of its dual-pronged approach to remove macroscopic disease via surgery, and removal of microscopic disease  \n1Laboratory of Applied Human Genetics, Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore. 2Division of Surgery and Surgical Oncology, Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), National Cancer Centre Singapore, Singapore, Singapore. 3Division of Surgery and Surgical Oncology, Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Singapore General Hospital, Singapore, Singapore. 4Department of Anatomical Pathology, Singapore General Hospital, Singapore, Singapore. 5SingHealth Duke-NUS Surgery Academic Clinical Program, Duke-NUS Medical School, Singapore, Singapore. 6SingHealth Duke-NUS Oncology Academic Clinical Program, Duke-NUS Medical School, Singapore, Singapore. 7Department of Head and Neck Surgery, Division of Surgery and Surgical Onco","cbCairvUXIV4GAvH","https://ap.wps.com/l/cbCairvUXIV4GAvH","pdf",1442252,"English","# Introduction\n## Immunotherapy and the tumor microenvironment\n## Rationale for targeting the peritoneal space\n# Methods and Analyses\n## Single-cell database screening for macrophage activation markers\n## VSIG4 expression assessment on tumor microarrays\n## VSIG4 measurement in cell-free ascites\n# Findings and Interpretation\n## Association of VSIG4 with prognosis in primary CRC\n## VSIG4 variability in CPM ascites\n## Implications for immunotherapeutic development","[{\"question\":\"What is the main goal of this study on VSIG4 in colorectal PM?\",\"answer\":\"To identify immunomodulatory factors associated with colorectal peritoneal metastases, focusing on the macrophage-related marker VSIG4 and its potential role in anti-inflammatory tumor microenvironments.\"},{\"question\":\"How was VSIG4 expression evaluated in the study?\",\"answer\":\"VSIG4 expression was assessed using immunohistochemical analysis on colorectal tumor microarrays, and its presence in cell-free ascites from PM patients was quantified using ELISA.\"},{\"question\":\"What relationship was observed between VSIG4 expression and patient prognosis?\",\"answer\":\"CRCTMA staining indicated that low VSIG4 expression in stromal tissues of primary colorectal cancer was associated with poorer prognosis.\"}]","The immunomodulatory role of paracrine signalling factor VSIG4 in peritoneal metastases | PDF",1790032346,23,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a2916f45de2d0637aeadda459c99638a.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cf80a53d6582caaebf58a63be035dc12.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/090fcf8071dacc6fc9865a46a7f1e66b.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/53f798e2d8830b05f7baf8b159c5c9d2.webp",980,1287]